AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Nika Pharmaceuticals Inc.

$0.41 +$0.03 (+7.87%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$0.41
Day Range
$0.41 - $0.41
Year Range
$0.2$0.97
Market Cap
429.91M
AVG Volume
657
Trailing/Forward PE
-5519.27/-
PEG ratio
55.19
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
-200-100010020024 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NIKA Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q20
26 Q10
25 Q40
25 Q3-156
25 Q2-156
25 Q10
24 Q40
24 Q3156
Net Income (USD) · TTM
-150K-100K-50K024 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NIKA Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q2-78.12K
26 Q1-76.81K
25 Q4-76.4K
25 Q3-51.78K
25 Q2-52.15K
25 Q1-88.56K
24 Q4-141.61K
24 Q3-136.47K
Operating Income (USD) · TTM
-150K-100K-50K024 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NIKA Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q2-78.12K
26 Q1-76.81K
25 Q4-76.4K
25 Q3-5.96K
25 Q2-6.33K
25 Q1-42.75K
24 Q4-95.79K
24 Q3-136.47K
EBITDA (USD) · TTM
-150K-100K-50K024 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NIKA EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q2-78.12K
26 Q1-76.81K
25 Q4-76.4K
25 Q3-28.67K
25 Q2-29.04K
25 Q1-65.46K
24 Q4-98.47K
24 Q3-109.12K
Cash Flows (USD) · TTM
-200K0200K400K24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NIKA Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q2-69.14K
26 Q1-80.07K
25 Q4-79.65K
25 Q3-53.25K
25 Q2352.52K
25 Q1-2.02K
24 Q4-139.08K
24 Q3-133.94K
EPS (USD) · TTM
-0-00024 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NIKA EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q20
26 Q10
25 Q40
25 Q30
25 Q20
25 Q10
24 Q4-0
24 Q3-0
Expenses (USD) · TTM
050K100K150K24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NIKA Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q278.12K
26 Q176.81K
25 Q476.4K
25 Q351.76K
25 Q252.15K
25 Q188.72K
24 Q4141.76K
24 Q3136.62K
Employee Count
00.511.522021
NIKA Employee Count by quarter
PeriodEmployee Count
20211
Free Cash Flow Yield
-0.05%0%0.05%0.1%0.15%med -0.01%Feb 25May 25Aug 25Nov 25Mar 26Jun 26Sep 26
NIKA Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-0.02%
Sep 26-0.02%
Sep 26-0.02%
Aug 26-0.02%
Aug 26-0.02%
Aug 26-0.02%
Aug 26-0.01%
Jul 26-0.04%
Jul 26-0.01%
Jul 26-0.01%
Jul 26-0.01%
Jul 26-0.01%
Jun 26-0.02%
Jun 26-0.01%
Jun 26-0.04%
Jun 26-0.04%
May 26-0.04%
May 26-0.01%
May 26-0.01%
May 26-0.02%
May 26-0.02%
Apr 26-0.02%
Apr 26-0.01%
Apr 26-0.01%
Apr 26-0.02%
Mar 26-0.01%
Mar 26-0.01%
Mar 26-0.01%
Mar 26-0.01%
Feb 26-0.01%
Feb 26-0.01%
Feb 26-0.01%
Feb 26-0.01%
Jan 26-0.01%
Jan 26-0.01%
Jan 26-0.01%
Jan 26-0.01%
Jan 26-0.01%
Dec 25-0.02%
Dec 25-0.02%
Dec 25-0.02%
Dec 25-0.02%
Nov 25-0.02%
Nov 25-0.02%
Nov 25-0.02%
Nov 25-0.02%
Oct 250.11%
Oct 250.11%
Oct 250.11%
Oct 250.11%
Oct 250.11%
Sep 250.12%
Sep 250.1%
Sep 250.04%
Sep 250.04%
Aug 250.04%
Aug 250.04%
Aug 250.04%
Aug 25-0%
Aug 25-0%
Jul 25-0%
Jul 25-0%
Jul 25-0%
Jul 25-0%
Jun 25-0%
Jun 25-0%
Jun 25-0%
Jun 25-0%
May 25-0%
May 25-0%
May 25-0%
May 25-0.01%
May 25-0.01%
Apr 25-0.01%
Apr 25-0.01%
Apr 25-0.01%
Apr 25-0.01%
Mar 25-0.01%
Mar 25-0.01%
Mar 25-0.01%
Mar 25-0.01%
Feb 25-0.01%
Feb 25-0.01%
Feb 25-0.01%
Feb 25-0.01%
Jan 25-0.01%
Jan 25-0.01%
Jan 25-0.02%
Jan 25-0.02%
Jan 25-0.03%
Dec 24-0.03%
Dec 24-0.03%
Dec 24-0.03%
Dec 24-0.03%
Nov 24-0.03%
Nov 24-0.03%
Nov 24-0.02%
Price to Sales
-10000000-50000000500000010000000med -1946355.28Dec 24Feb 25Sep 25Nov 25Jan 26Mar 26
NIKA Price to Sales by quarter
PeriodPrice to Sales
Mar 26-5035872.42
Mar 26-5035872.42
Mar 26-5035872.42
Feb 26-5035872.42
Feb 26-5035872.42
Feb 26-5035872.42
Feb 26-2586258.77
Jan 26-2586258.77
Jan 26-2532933.85
Jan 26-2532933.85
Jan 26-2533600.41
Jan 26-2533600.41
Dec 25-1866372.31
Dec 25-1866372.31
Dec 25-1866372.31
Dec 25-1666403.85
Nov 25-1666403.85
Nov 25-1999684.62
Nov 25-1999684.62
Nov 25-1999684.62
Oct 25-1973857.69
Oct 25-2121897.02
Oct 25-2121897.02
Oct 25-2121897.02
Oct 25-2121897.02
Sep 25-1918852.86
Sep 25-2375866.71
Sep 25-6299237.85
Sep 25-6299237.85
Aug 25-6233442.59
Aug 25-6236732.36
Aug 25-6236732.36
Mar 256528971.15
Mar 256528971.15
Mar 256528971.15
Mar 256528971.15
Feb 256528971.15
Feb 256528971.15
Feb 256528971.15
Feb 256528971.15
Jan 256528971.15
Jan 256528971.15
Jan 253871679.89
Jan 253852092.98
Jan 253311624.75
Dec 243311624.75
Dec 243311624.75
Dec 243311624.75
Dec 243311624.75
Nov 243311624.75
Nov 243311624.75
Nov 243852092.98
Price/Operating Cashflow
0200040006000med 2888.36Nov 24Jan 25Mar 25May 25Jul 25Sep 25Oct 25
NIKA Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Oct 25914.62
Oct 25983.21
Oct 25983.21
Oct 25983.21
Oct 25983.21
Sep 25889.13
Sep 251100.9
Sep 252918.85
Sep 252918.85
Aug 252888.36
Aug 252889.89
Aug 252889.89
Aug 253028.26
Aug 253028.26
Jul 252204.34
Jul 252204.34
Jul 252204.34
Jul 252204.34
Jun 252204.34
Jun 252204.34
Jun 252204.34
Jun 252074.96
May 252076.24
May 252094.25
May 252094.25
May 255529.09
May 255529.09
Apr 255529.09
Apr 255529.09
Apr 255529.09
Apr 255529.09
Mar 254963.55
Mar 254963.55
Mar 254963.55
Mar 254963.55
Feb 254963.55
Feb 254963.55
Feb 254963.55
Feb 254963.55
Jan 254963.55
Jan 254963.55
Jan 252943.38
Jan 252928.49
Jan 252517.61
Dec 242517.61
Dec 242517.61
Dec 242517.61
Dec 242517.61
Nov 242517.61
Nov 242517.61
Nov 242928.49
Nika Pharmaceuticals Inc.
NIKA
Stockpicker

Video analysis: NIKA

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: NIKA

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.